Welcoming a New CEO

Welcoming a New CEO

April 1, 2026 marks Dr. Sanjay Ahuja’s first day as CEO & Medical Director of Innovative Hematology. As we look ahead, our focus now is clear: to build on the strong foundation already in place, strengthen the continuity of care our patients depend on, and...
Clinical Pearls for Managing Women with Thrombosis

Clinical Pearls for Managing Women with Thrombosis

Thrombosis in women presents unique clinical challenges due to sex-specific risk factors, hormonal influences, and reproductive considerations. While the core principles of venous thromboembolism (VTE) management apply broadly, tailoring care to the female patient can...
Five questions for Dr. Sanjay P. Ahuja, Innovative Hematology incoming CEO

Letter from Chair of the Board

I am pleased to announce that the Innovative Hematology Board of Directors has appointed Sanjay P. Ahuja, MD, MSc, MBA as the organization’s new Chief Executive Officer & Medical Director of Innovative Hematology, effective April 1, 2026.  Dr. Ahuja’s impressive...